Central adenosine A(2A) receptors: An overview

Brain Research Reviews

Volumn 31, Issue 1, 1999, Pages 65-82

  Moreau, Jean Luc ^a   Huber, Gerda ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

A(2A) receptor; Adenosine; Behavioural function; Neuropsychiatric disorder

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENYLATE CYCLASE; DOPAMINE 2 RECEPTOR; LEVODOPA; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

BEHAVIOR; BRAIN ISCHEMIA; CLINICAL TRIAL; CORPUS STRIATUM; HUMAN; MICROGLIA; NEUROPSYCHIATRY; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVIEW; SEIZURE; SLEEP DISORDER;

EID: 0033408368     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00059-4     Document Type: Review

References (194)

1. 2A receptor agonists on pentylenetetrazol-induced convulsions in the rat Eur. J. Pharmacol. 294 1995 383 389
2. M.K. Ahlijanian A.E. Takemori Effects of (−)-N6-( R -phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice Eur. J. Pharmacol. 112 1985 171 179
3. 2 adenosine receptor-adenylate cyclase system in vascular smooth muscle cells from rat aorta Mol. Cell. Endocrinol. 62 1989 273 279
4. 2 receptor-selective ligands on brain stimulation reward thresholds in the rat Soc. Neurosci. Abstr. 22 1996 271.3
5. 2 receptor-selective drugs on brain stimulation reward thresholds in the rat Behav. Pharmacol. 9 1998 S12 Suppl. 1
6. H.A. Baldwin A. Johnston S.E. File Antagonistic effects of caffeine and yohimbine in animal tests of anxiety Eur. J. Pharmacol. 159 1989 211 215
7. R.A. Barraco T.H. Swanson J.W. Phillis R.F. Berman Anticonvulsant effects of adenosine analogues on amygdaloid-kindled seizures in rats Neurosci. Lett. 46 1984 317 322
8. 2A receptors in the nucleus accumbens Prog. Neuro-psychopharmacol. Biol. Psychiatry 18 1994 545 553
9. 2A receptors associated with norepinephrine release and their desensitization in the rat nucleus tractus solitarius J. Neurochem. 65 1995 1604 1611
10. 3 H ]SCH58261 to coronary artery membranes Circ. Res. 79 1996 1153 1160
11. M. Belfrage M. Segerdahl S. Arner A. Sollevi The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain Anesth. Analg. 89 1999 136 142
12. K. Blüml E. Mutschler J. Wess Identification of an intracellular tyrosine residue critical for muscarinic receptor-mediated stimulation of phosphatidylinositol hydrolysis J. Biol. Chem. 269 1994 402 405
13. E. Bona U. Aden E. Gilland B.B. Fredholm H. Hagberg Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists Neuropharmacology 36 1997 1327 1338
14. J.P. Boulenger T.W. Uhde E.A. Wolf R.M. Post Increased sensitivity to caffeine in patients with panic disorders: preliminary evidence Arch. Gen. Psychiatry 41 1984 1067 1071
15. 2 adenosine receptor subtypes in locomotion activity and place conditioning in rats Behav. Pharmacol. 7 1986 373 383
16. 2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells J. Neurochem. 69 1997 1300 1309
17. D.S. Charney G.R. Heninger P.I. Jatlow Increased anxiogenic effects of caffeine in panic disorders Arch. Gen. Psychiatry 42 1985 233 243
18. 2A adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells Mol. Pharmacol. 44 1993 950 958
19. A.H. Cheung R.R. Huang C.D. Strader Involvement of specific hydrophobic, but not hydrophilic, amino acids in the third intracellular loop of the beta-adrenergic receptor in the activation of Gs Mol. Pharmacol. 41 1992 1061 1065
20. 2A adenosine receptor gene DNA Cell Biol. 15 1996 329 337
21. A. Contreras A. Germany M. Villar Effects of some adenosine analogs on morphine-induced analgesia and tolerance Gen. Pharmacol. 21 1990 763 767
22. C. Corsi M. Pazzagli L. Bianchi L. Della Corte G. Pepeu F. Pedata In vivo amino acid release from the striatum of aging rats: adenosine modulation Neurobiol. Aging 18 1997 243 250
23. +-evoked glutamate release in vivo in young and aged rats NeuroReport 10 1999 687 691
24. 2A receptors in the rat hippocampus Brain Res. 649 1994 208 216
25. 2A receptor binding in aged striatum, hippocampus and cortex of the rat NeuroReport 6 1995 1583 1588
26. 2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus Neurosci. Lett. 196 1995 41 44
27. 2A receptors Naunyn-Schmiedberg's Arch. Pharmacol. 359 1999 295 302
28. J.W. Daly D. Shi V. Wong O. Nikodijevic Chronic effects of ethanol on central adenosine function of mice Brain Res. 650 1994 153 156
29. J.W. Daly B.B. Fredholm Caffeine — an atypical drug of dependence Drug Alcohol Depend. 51 1998 199 206
30. M.S. Dar Functional correlation between subclasses of brain adenosine receptor affinities and ethanol-induced motor in coordination in mice Pharmacol. Biochem. Behav. 37 1990 747 753
31. 2 receptors Pharmacol. Ther. 71 1996 325 335
32. 2A receptor gene: systematic mutation screening in patients with schizophrenia J. Neural Transm. 103 1996 1447 1455
33. 2A receptor gene: relationship to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 region Hum. Genet. 99 1997 326 328
34. 2A receptor knockout mouse: a model for anxiety? Int. J. Neuropsychopharmacol. 1 1998 187 190
35. 2A gene to the development of disease Mol. Psychiatry 3 1998 81 85
36. E. DeMet M.K. Stein C. Tran A. Chicz-DeMet C. Sangdahl J. Nelson Caffeine taste test for panic disorder: adenosine receptor supersensitivity Psychiatry Res. 30 1989 231 242
37. 2 receptor function in morphine dependent rats Pharmacol. Res. 25 1992 232 233
38. G. De Sarro A. De Sarro E.D. Di Paola R. Bertorelli Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice Eur. J. Pharmacol. 371 1999 137 145
39. A.K. Dixon A.K. Gubitz D.J. Sirinathsinghji P.J. Richardson T.C. Freeman Tissue distribution of adenosine receptor mRNAs in the rat Br. J. Pharmacol. 118 1996 1461 1468
40. M. Dragunow Purinergic mechanisms in epilepsy Prog. Neurobiol. 31 1998 85 108
41. T.V. Dunwiddie The physiological role of adenosine in the central nervous system Int. Rev. Neurobiol. 27 1985 63 139
42. T.V. Dunwiddie T. Worth Sedative and anticonvulsant effects of adenosine analogs in mouse and rat J. Pharmacol. Exp. Ther. 220 1982 70 76
43. 2 receptor involvement in the hypomobility effects of adenosine analogues in mice Eur. J. Pharmacol. 168 1989 285 290
44. 2A-adrenergic receptor. Evidence for distinct structural determinants that confer Gs versus Gi coupling J. Biol. Chem. 270 1995 24753 24760
45. M. El Yacoubi J. Costentin J.-M. Vaugeois Drugs acting on adenosine receptors and anxiety in the mouse Eur. Neuropsychopharmacol. 8 1998 S270 Suppl. 2
46. 2A receptor antagonism potentiates L-DOPA turning behavior and c-Fos expression in 6-hydroxydopamine-lesioned rats Eur. J. Pharmacol. 321 1997 143 147
47. 2 receptors in rat striatal membranes Proc. Natl. Acad. Sci. U.S.A. 88 1991 7238 7241
48. 2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia Neuroscience 63 1994 765 773
49. S. Ferre Adenosine-dopamine interactions in the ventral striatum Psychopharmacology 133 1997 107 120
50. S. Ferre B.B. Fredholm M. Morelli P. Popoli K. Fuxe Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia Trends Neurosci. 20 1997 482 487
51. 2A receptors Glia 18 1996 152 160
52. 1 receptors modulate anxiety in CD1 mice Psychopharmacology 136 1998 311 319
53. P. Forsythe M. Ennis Adenosine, mast cells and asthma Inflamm. Res. 48 1999 301 307
54. B.B. Fredholm Purinoceptors in the nervous system Pharmacol. Toxicol. 76 1995 228 239
55. B.B. Fredholm B. Johansson K. Lindstrom G. Wahlstrom Age-dependent changes in adenosine receptors are not modified by life-long intermittent alcohol administration Brain Res. 791 1998 177 185
56. B.B. Fredholm K. Battig J. Holmen A. Nehlig E.E. Zvartai Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol. Rev. 52 1999 83 133
57. 2 receptor Brain. Res. Mol. Brain Res. 15 1992 62 66
58. 1 receptor interactions in the basal ganglia Brain Res. Rev. 26 1998 258 273
59. B.D. Garfinkel C.D. Webster L. Sloman Responses to methylphenidate and varied doses of caffeine in children with attention deficit disorder Can. J. Psychiatry 26 1981 395 401
60. 1 receptor agonist Eur. J. Pharmacol. 357 1998 149 155
61. 1-selective antagonist, DPCPX Psychopharmacology 103 1991 541 544
62. 2A receptor antagonist in MPTP-treated monkeys Neurology 52 1999 1673 1677
63. 2A receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals J. Neurochem. 67 1996 374 381
64. R. Guieu F. Couraud J. Pouget F. Sampieri G. Bechis H. Rochat Adenosine and the nervous system: clinical implications Clin. Neuropharmacol. 19 1996 459 474
65. 2A receptors in the nucleus accumbens modulate prepulse inhibition of the startle response NeuroReport 8 1997 1515 1518
66. 2A receptors in the nucleus accumbens and the caudate-putamen Eur. J. pharmacol. 323 1997 127 131
67. 2A receptors in the caudate–putamen NeuroReport 9 1998 1803 1806
68. 3 receptors J. Pharmacol. Exp. Ther. 280 1997 122 128
69. D. Hill-Eubanks E.S. Burstein T.A. Spalding H. Brauner-Osborne M.R. Brann Structure of a G-protein-coupling domain of a muscarinic receptor predicted by random saturation mutagenesis J. Biol. Chem. 271 1996 3058 3065
70. 2A receptor to inhibition of the mitogen-activated protein kinase cascade in Chinese hamster ovary cells Biochem. J. 316 1996 81 86
71. M. Holmgren J. Hedner T. Mellstrand G. Nordberg T. Hedner Characterization of the antinociceptive effects of some adenosine analogues in the rat Naunyn-Schmiedberg's Arch. Pharmacol. 334 1986 290 293
72. J.R. Hughes P. McHugh S. Holtzman Caffeine and schizophrenia Psychiatr. Serv. 49 1998 1415 1417
73. J.R. Hughes K.L. Hale Behavioral effects of caffeine and other methylxanthines on children Exp. Clin. Psychopharmacol. 6 1998 87 95
74. A.P. Hyde Response to “Effects of caffeine on behavior of schizophrenic inpatients” Schizophr. Bull. 16 1990 371 372
75. I. Iancu O.T. Dolberg J. Zohar Is caffeine involved in the pathogenesis of combat-stress reaction? Mil. Med. 161 1996 230 232
76. 2A receptor Eur. J. Pharmacol. 268 1994 95 104
77. M. Imaizumi S. Miyazaki K. Onodera Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors Methods Find. Exp. Clin. Pharmacol. 16 1994 639 644
78. 2A adenosine receptors Mol. Pharmacol. 42 1992 123 133
79. N. Jain N. Kemp O. Adeyemo P. Buchanan T.W. Stone Anxiolytic activity of adenosine receptor activation in mice Br. J. Pharmacol. 116 1995 2127 2133
80. 2A, receptor density in mouse brain Brain Res. 786 1998 80 88
81. F. Jenck J.-L. Moreau J.R. Martin Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity Psychiatry Res. 57 1995 181 191
82. 2A adenosine receptors are required for ligand recognition Mol. Pharmacol. 50 1996 512 521
83. 3 H ]CGS 21680 to rat brain using autoradiography Neuropharmacology 34 1995 393 403
84. 2A receptors in rat brain: comparison with dopamine receptors Neuroscience 80 1997 1187 1207
85. 2A receptor antagonist Brain Res. 800 1998 328 335
86. 2A receptors gene in the olfactory bulb and spinal cord of rat and mouse Neurosci. Lett. 261 1999 189 191
87. 2 receptor interactions in animal models of schizophrenia Eur. J. Pharmacol. 295 1996 147 154
88. 2A receptor antagonist with anticataleptic activity Eur. J. Pharmacol. 256 1994 263 268
89. 2A receptors modify motor function in MPTP-treated common marmosets NeuroReport 9 1998 2857 2860
90. 2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys Ann. Neurol. 43 1998 507 513
91. G.B. Kaplan M.T. Sears Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs Psychopharmacology 123 1996 64 70
92. 1 adenosine receptor Neurosci. Lett. 121 1991 267 270
93. 2A adenosine receptor J. Biol. Chem. 270 1995 13987 13997
94. K.A. Kirkpatrick P.J. Richardson Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes Br. J. Pharmacol. 110 1993 949 954
95. E. Klein J. Zohar M.F. Geraci D.L. Murphy T.W. Uhde Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects Biol. Psychiatry 30 1991 973 984
96. 2A receptor-mediated inhibition of calcium current in rat PC12 cells via downregulation of protein kinase J. Physiol. (London) 512 1998 351 363
97. 2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection J. Biol. Chem. 274 1999 20358 20565
98. M. Koch W. Hauber Regulation of sensorimotor gating by interactions of dopamine and adenosine in the rat Behav. Pharmacol. 9 1998 23 29
99. E. Kowaluk Adenosine modulation: a novel approach to analgesia and inflammation Exp. Opin. Invest. Drugs 7 1998 535 543
100. 2A receptor-mediated modulation of striatal acetylcholine release in vivo J. Neurochem. 66 1996 1882 1888
101. 3 H ]CGS21680 binding in the striatum of postmortem brains of chronic schizophrenics, Brain Res. (1998) 320–323.
102. 2A-adenosine receptor-mediated cAMP response J. Biol. Chem. 272 1997 4970 4977
103. 2 adenosine receptors: their presence and neuromodulatory role in the central nervous system Gen. Pharmacol. 27 1996 925 933
104. 2A Biochem. Biophys. Res. Commun. 223 1996 461 467
105. 2A receptor Nature 388 1997 674 678
106. Y.W. Lee T.L. Yaksh Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists J. Pharmacol. Exp. Ther. 277 1996 1642 1648
107. S.B. Liggett M.G. Caron R.J. Lefkowitz M. Hnatowich Coupling of a mutated form of the human beta2-adrenergic receptor to Gi and Gs. Requirement for multiple cytoplasmic domains in the coupling process J. Biol. Chem. 266 1991 4816 4821
108. 3 receptors: pharmacological properties, species differences and receptor functions Trends Pharmacol. Sci. 15 1994 298 306
109. 2A receptor SCH58261 discriminates between two different binding sites for [3H]-CGS21680 in the rat brain Naunyn-Schmiedberg's Arch. Pharmacol. 354 1996 539 541
110. P.B. Lucas D. Pickar J. Kelsoe M. Rapaport C. Pato D. Hommer Effects of the acute administration of caffeine in patients with schizophrenia Biol. Psychiatry 28 1990 35 40
111. M. Maitre L. Ciesielski A. Lehmann E. Kempf P. Mandel Protective effect of adenosine and nicotinamide against audiogenic seizures Biochem. Pharmacol. 23 1974 2807 2816
112. J. Mally T.W. Stone The effect of theophylline on parkinsonian symptoms J. Pharm. Pharmacol. 46 1994 515 517
113. 2 receptors modulate haloperidol-induced catalepsy in rats Eur. J. Pharmacol. 328 1997 135 141
114. 1 receptors, using in vivo and in vitro techniques J. Pharmacol. Exp. Ther. 285 1998 1023 1030
115. D.L. Marquardt L.L. Walker S. Heinemann Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells J. Immunol. 152 1994 4508 4515
116. 2A adenosine receptor from guinea pig brain Neurochem. Res. 19 1994 613 621
117. E. Mikkelsen Caffeine and schizophrenia J. Clin. Psychiatry 39 1978 732 736
118. T.R. Minor W.C. Chang J.L. Winslow Stress and adenosine: I. Effect of methylxanthine and amphetamine stimulants on learned helplessness in rats Behav. Neurosci. 108 1994 254 264
119. T.R. Minor J.L. Winslow W.C. Chang Stress and adenosine: II. Adenosine analogs mimic the effect of inescapable shock on shuttle-escape performance in rats Behav. Neurosci. 108 1994 265 276
120. 2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischemia in rats NeuroReport 9 1998 3955 3959
121. 2A adenosine receptor antagonist, SCH58261, in the rat J. Pharmacol. Exp. Ther. 285 1998 9 15
122. G.K. Mumford S.G. Holtzman Methylxanthines elevate reinforcement threshold for electrical brain stimulation: role of adenosine receptors and phosphodiesterase inhibition Brain Res. 528 1990 32 38
123. G.K. Mumford S.G. Holtzman Do adenosinergic substrates mediate methylxanthine effects upon reinforcement thresholds for electrical brain stimulation in the rat? Brain Res. 550 1991 172 178
124. T.F. Murray D. Sylvester C.S. Schultz P. Szot Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat Neuropharmacology 24 1985 761 767
125. 3 receptor gene FEBS Lett. 384 1996 243 246
126. A. Nehlig G. Lucignini M. Kaderako L.J. Porrino I. Sokoloff Effects of acute adminsitration of caffeine on local cerebral glucose utilization in the rat Eur. J. Pharmacol. 101 1984 91 100
127. M.E. Newman A. Levitzki Desensitization of normal rat kidney cells to adenosine Biochem. Pharmacol. 32 1983 137 140
128. 1 receptors Brain Res. Bull. 27 1991 101 104
129. 1 receptors in the nucleus accumbens impairs inhibitory avoidance memory Behav. Neural Biol. 62 1994 163 166
130. Y. Okada T. Sakurai M. Mori Excitatory effects of adenosine on neurotransmission is due to increase of transmitter release in the hippocampal slices Neurosci. Lett. 142 1992 233 236
131. M.E. Olah G.L. Stiles Adenosine receptor subtypes: characterization and therapeutic regulation Annu. Rev. Pharmacol. Toxicol. 35 1995 581 606
132. 2A adenosine receptors J. Biol. Chem. 272 1997 337 344
133. 2A receptors Trends Pharmacol. Sci. 17 1996 364 372
134. 2A receptors and neuroprotection Ann. NY Acad. Sci. 825 1997 30 48
135. M.H. O'Regan R.E. Simpson L.M. Perkins J.W. Phillis Adenosine receptor agonists inhibit the release of gamma-aminobutyric acid (GABA) from the ischemic rat cerebral cortex Brain Res. 582 1992 22 26
136. 2A adenosine receptor: delineation of multiple processes Mol. Pharmacol. 45 1994 1082 1094
137. 2A adenosine receptor domain specifically responsible for mediating short-term desensitization Biochemistry 36 1997 832 838
138. 2A receptors in the rat striatum: implications for the mechanism and the treatment of tardive dyskinesia J. Neurochem. 65 1995 2057 2064
139. 2A adenosine receptor gene J. Neurochem. 66 1996 362 368
140. 2A receptor mRNA expression in SH-SY5Y cells Eur. J. Pharmacol. 336 1997 71 80
141. 2A adenosine receptor antagonists on cerebral ischemic injury in the gerbil Brain Res. 705 1995 79 84
142. 2B receptor from human brain Biochem. Biophys. Res. Commun. 187 1992 86 93
143. 2A adenosine receptors retain ligand binding Mol. Pharmacol. 45 1994 861 870
144. 1 agonists in dopamine-denervated rats Eur. J. Pharmacol. 8 1996 1176 1181
145. 2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas Brain Res. 759 1997 41 49
146. 2A receptors in the induction of C-Fos expression by clozapine and haloperidol Neuropsychopharmacology 20 1999 44 51
147. A. Poon J. Sawynok Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat Pain 74 1998 235 245
148. P. Popoli P. Betto R. Rimondini R. Reggio A. Pezzola G. Ricciarello K. Fuxe S. Ferre Age-related alteration of the adenosine/dopamine balance in the rat striatum Brain Res. 795 1998 297 300
149. C.M. Portas M. Thakkar D.G. Rainnie R.W. Greene R.W. McCarley Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat Neuroscience 79 1997 225 235
150. S.-A. Poulsen R.J. Quinn Adenosine receptors: new opportunities for future drugs Bioorg. Med. Chem. 6 1998 619 641
151. M. Radulovacki R.M. Virus M. Djuticic-Nedelson R.D. Green Adenosine analogs and sleep in rats J. Pharmacol. Exp. Ther. 228 1984 268 2774
152. J.A. Ribeiro R.A. Cunha P. Correia-de-Sa A.M. Sebastiao Purinergic regulation of acetylcholine release Prog. Brain Res. 109 1996 231 241
153. 2A receptor interactions with receptors for other neurotransmitters and neuromodulators Eur. J. Pharmacol. 375 1999 101 113
154. 2A receptor antagonists as new agents for the treatment of Parkinson's disease Trends Pharmacol. Sci. 18 1997 338 344
155. M. Rihs C. Muller P. Baumann Caffeine consumption in hospitalized psychiatric patients Eur. Arch. Psychiatry Clin. Neurosci. 246 1996 83 92
156. 2A agonists: a potential new type of atypical antipsychotic Neuropsychopharmacology 17 1997 82 91
157. 2A receptor agonists on dopamine receptor agonist-induced behavioral responses in rats Eur. J. Pharmacol. 347 1998 153 158
158. 2A receptors in the rat central nervous system J. Comp. Neurol. 401 1998 163 186
159. K.A. Rudolphi P. Schubert F.E. Parkinson B.B. Fredholm Neuroprotective role of adenosine in cerebral ischaemia Trends Pharmacol. Sci. 13 1992 439 445
160. 2A adenosine receptor mRNA expression by agonists and forskolin in PC12 cells NeuroReport 5 1994 1317 1320
161. 3 adenosine receptor variant FEBS Lett. 382 1996 125 129
162. A. Salem W. Hope Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats Pharmacol. Biochem. Behav. 57 1997 671 679
163. A. Salem W. Hope Role of endogenous adenosine in the expression of opiate withdrawal in rats Eur. J. Pharmacol. 369 1999 39 42
164. 3 adenosine receptor Proc. Natl. Acad. Sci. U.S.A. 90 1993 10365 10369
165. 2A adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats Proc. Natl. Acad. Sci. U.S.A. 93 1996 5980 5984
166. 2A receptor in sleep promotion Eur. J. Pharmacol. 351 1998 155 162
167. 2A receptor agonist Eur. J. Neurosci. 11 1999 1587 1597
168. J. Sawynok Adenosine receptor activation and nociception Eur. J. Pharmacol. 347 1998 1 11
169. R.C. Schnackenburg Caffeine as a substitute for schedule II stimulants in hyperkinetic children Am. J. Psychiatry 130 1973 796 798
170. B. Schwierin A.A. Borbely I. Tobler Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat Eur. J. Pharmacol. 300 1996 163 171
171. 2 receptor-mediated excitatory actions on the nervous system Prog. Neurobiol. 48 1996 167 189
172. R.E. Simpson M.H. O'Regan L.M. Perkins J.W. Phillis Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists J. Neurochem. 58 1992 1683 1690
173. A. Sollevi Adenosine for pain control Acta Anaesthesiol. Scand., Suppl. 110 1997 135 136
174. M.B. Stein B. Black T.M. Brown T.W. Uhde Lack of efficacy of the adenosine reuptake inhibitor dipyridamole in the treatment of anxiety disorders Biol. Psychiatry 33 1993 647 650
175. H.W. Suh D.K. Song Y.H. Kim Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the mouse Neuropeptides 31 1997 339 344
176. G.W. Sullivan J. Linden Role of A2A adenosine receptors in inflammation Drug Dev. Res. 45 1998 103 112
177. P. Svenningsson H. Hall G. Sedvall B.B. Fredholm Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study Synapse 27 1997 322 335
178. 2A receptor mRNA in the primate striatum J. Comp. Neurol. 399 1998 229 240
179. P. Svenningsson L. Fourreau B. Bloch B.B. Fredholm F. Gonon C. Le Moine Opposite tonic modulation of dopamine and adenosine on c- fos gene expression in striatopallidal neurons Neuroscience 89 1999 827 837
180. J.M. Taylor G.G. Jacob-Mosier R.G. Lawton M. VanDort R.R. Neubig Receptor and membrane interaction sites on Gbeta. A receptor-derived peptide binds to the carboxyl terminus J. Biol. Chem. 271 1996 3336 3339
181. 2A agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens Brain Res. 707 1996 75 80
182. J.J. Valdes P.S. McGuire Z. Annau Xanthines alter behaviour maintained by intracranial electrical stimulation and an operant schedule Psychopharmacology 76 1982 325 328
183. 2 receptors: structure-function relationship Med. Res. Rev. 12 1992 423 471
184. 2A adenosine receptors in human neutrophil membranes Br. J. Pharmacol. 123 1998 1723 1731
185. R.M. Virus M. Djuricic-Nedelson M. Radulovacki R.D. Green The effects of adenosine and 2′-deoxycoformycin on sleep and wakefulness in rats Neuropharmacology 22 1983 1401 1404
186. 2A receptor agonist and antagonist Eur. J. Pharmacol. 287 1995 295 302
187. D.K. Von Lubitz Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol. 365 1999 9 25
188. 6 receptors following antipsychotic administration Neuroscience 89 1999 927 938
189. D.R. Weaver S.M. Reppert Adenosine receptor gene expression in rat kidney Am. J. Physiol. 263 1992 F991 F995
190. M. Williams Purinergic pharmaceuticals for the 1990s Nucleosides and nucleotides 10 1991 1087 1099
191. M. Williams Purinergic drugs: opportunities in the 1990s Drug Dev. Res. 28 1993 438 444
192. J.C. Woodson T.R. Minor R.F. Soames Job Inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) mimics the effect of inescapable shock on escape learning in rats Behav. Neurosci. 112 1998 399 409
193. M.R. Zarrindast A.A. Moghadamnia Adenosine receptor agents and conditioned place preference Gen. Pharmacol. 29 1997 285 289
194. M.R. Zarrindast B. Naghipour F. Roushan-Zamir B. Shafaghi Effects of adenosine receptor agents on the expression of morphine withdrawal in mice Eur. J. Pharmacol. 369 1999 17 22